Regeneron’s Billionaire Founder Battles The Drug Pricing System

Regeneron’s Billionaire Founder Battles The Drug Pricing System - "It's not simply about just growing your earnings per share by raising your price," Schleifer says. "So, yes, I'm glad I've been outspoken, because I think that I am trying to prevent what is still at risk of happening: If the industry does not behave properly, the government is going to step in."